Deutsch English Français

Contact

EP1812065

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1812065

EP1812065 - HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.03.2013 Database last updated on 01.02.2025
Most recent event Tooltip	08.03.2013	Application deemed to be withdrawn	published on 10.04.2013 [2013/15]
Applicant(s)	For all designated states MedImmune, LLC One MedImmune Way Gaithersburg, MD 20878 / US
	[2010/42]
Former [2007/31]	For all designated states MEDIMMUNE, INC. One MedImmune Way Gaithersburg, MD 20878 / US
Inventor(s)	01 / COYLE, Anthony 1155 23rd Street Washington, DC 20037 / US
	02 / WU, Herren 14405 Harvest Moon Road Boyds, MD 20841 / US
	03 / ALLAN, Christian, B. 4401 Gregg Road Brookeville, MD 20833 / US
	04 / GAO, Changshou 10822 Maplecrest Lane Potomac, MD 20854 / US
	05 / AN, Ling-Ling 14405 Harvest Moon Road Boyds, MD 20841 / US
	06 / KIENER, Peter 14017 Gorky Drive Potomac, MD 20854 / US
	07 / MAO, Su-Yau 7101 Cypress Hill Drive Gaithersburg, MD 20879 / US
	[2007/41]
Former [2007/31]	01 / COYLE, Anthony 14405 Harvest Moon Road Boyds, MD 20841 / US
	02 / WU, Herren 4401 Gregg Road Brookeville, MD 20833 / US
	03 / ALLAN, Christian, B. 10822 Maplecrest Lane Potomac, MD 20854 / US
	04 / GAO, Changshou 14405 Harvest Moon Road Boyds, MD 20841 / US
	05 / AN, Ling-Ling 14017 Gorky Drive Potomac, MD 20854 / US
	06 / KIENER, Peter 7101 Cypress Hill Drive Gaithersburg, MD 20879 / US
	07 / MAO, Su-Yau 1155 23rd Street Washington, DC 20037 / US
Representative(s)	Snodin, Michael D., et al Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB
	[N/P]
Former [2011/32]	Snodin, Michael D., et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB
Former [2011/25]	Bates, Rosica Florence, et al Medlmmune Ltd. Milstein Building Granta Park Cambridge CB21 6GH / GB
Former [2010/42]	Snodin, Michael D., et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB
Former [2009/48]	Linderoth, Margareta, et al AstraZenaca AB Global Intellectual Property 151 85 Södertälje / SE
Former [2008/18]	Linderoth, Margareta, et al AstraZeneca AB AstraZeneca Intellectual Property 151 85 Södertälje / SE
Former [2008/15]	Farquharson, Andrew AstraZeneca Global Intellectual Property London Office 15 Stanhope Gate London W1K 1LN / GB
Former [2008/01]	Farquharson, Andrew, et al AstraZeneca Global Intellectual Property London Office 15 Stangate Gate London W1K 1LN / GB
Former [2007/31]	Chapman, Paul Gilmour, et al Marks & Clerk Scotland 19 Royal Exchange Square Glasgow G1 3AE Scotland / GB
Application number, filing date	05858252.9	21.10.2005
	[2007/31]
	WO2005US37734
Priority number, date	US20040620726P	22.10.2004 Original published format: US 620726 P
	US20050651512P	10.02.2005 Original published format: US 651512 P
	US20050658572P	07.03.2005 Original published format: US 658572 P
	US20050662944P	18.03.2005 Original published format: US 662944 P
	US20050713712P	06.09.2005 Original published format: US 713712 P
	[2007/31]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2007001422
	Date:	04.01.2007
	Language:	EN
	[2007/01]
	Type:	A2 Application without search report
	No.:	EP1812065
	Date:	01.08.2007
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
	[2007/31]
Search report(s)	International search report - published on:	US	15.11.2007
	(Supplementary) European search report - dispatched on:	EP	04.08.2009
Classification	IPC:	A61K39/395, G01N33/53	[2008/14]
	CPC:	C07K16/24 (EP,US); A61K39/395 (KR); A61P1/04 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P29/00 (EP); (+) A61P31/04 (EP); A61P37/06 (EP); C07K16/40 (KR); A61K2039/505 (EP,US); C07K2317/21 (EP,US); C07K2317/55 (EP,US); C07K2317/565 (EP,US); C07K2317/76 (EP,US); C07K2317/92 (EP,US); C07K2319/30 (EP,US); Y02A50/30 (EP,US) (-)
	Former IPC [2008/01]	A61K39/395, G01N33/53, C07K16/40
	Former IPC [2007/31]	A61K39/395, C07K16/40
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/31]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	HOCHAFFINE ANTIKÖRPER GEGEN HMGB1 UND ANWENDUNGSVERFAHREN DAFÜR	[2007/31]
	English:	HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF	[2007/31]
	French:	ANTICORPS D'AFFINITÉ ÉLEVÉE CONTRE LA HMGB1 ET PROCÉDÉS D'UTILISATION	[2007/31]
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	26.04.2007	National basic fee paid
	26.04.2007	Search fee paid
	26.04.2007	Designation fee(s) paid
	26.04.2007	Examination fee paid
Examination procedure	26.04.2007	Examination requested [2007/31]
	19.10.2009	Amendment by applicant (claims and/or description)
	15.04.2010	Despatch of a communication from the examining division (Time limit: M08)
	21.12.2010	Reply to a communication from the examining division
	09.03.2012	Cancellation of oral proceeding that was planned for 12.03.2012
	12.03.2012	Date of oral proceedings (cancelled)
	15.03.2012	Despatch of a communication from the examining division (Time limit: M06)
	26.09.2012	Application deemed to be withdrawn, date of legal effect [2013/15]
	02.11.2012	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/15]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.04.2010
Fees paid	Renewal fee
	29.10.2007	Renewal fee patent year 03
	28.03.2008	Renewal fee patent year 04
	26.10.2009	Renewal fee patent year 05
	25.10.2010	Renewal fee patent year 06
	25.10.2011	Renewal fee patent year 07
	Penalty fee
	Additional fee for renewal fee
	31.10.2012	08 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]US2003143194 (TRACEY KEVIN J [US], et al) [Y] 1-23 * 0124-0125; 0127; 0132-0133; 0145-0146; 0164-0167; 0170-0179; claims *;
		[Y] - YAMADA S ET AL, "HIGH MOBILITY GROUP PROTEIN 1 (HMGB1) QUANTIFIED BY ELISA WITH A MONOCLONAL ANTIBODY THAT DOES NOT CROSS-REACT WITH HMGB2", CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC, (20030901), vol. 49, no. 9, ISSN 0009-9147, pages 1535 - 1537, XP001205689 [Y] 1-23 * the whole document * DOI: http://dx.doi.org/10.1373/49.9.1535
		[Y] - WINTER G ET AL, "MAKING ANTIBODIES BY PHAGE DISPLAY TECHNOLOGY", ANNUAL REVIEW OF IMMUNOLOGY, ANNUAL REVIEWS INC, US, (19940101), vol. 12, ISSN 0732-0582, pages 433 - 455, XP000564245 [Y] 1-23 * the whole document * DOI: http://dx.doi.org/10.1146/annurev.iy.12.040194.002245
		[Y] - BALINT R F ET AL, "ANTIBODY ENGINEERING BY PARSIMONIOUS MUTAGENESIS", GENE, ELSEVIER, AMSTERDAM, NL, (19931227), vol. 137, no. 1, ISSN 0378-1119, pages 109 - 118, XP002031537 [Y] 1-23 * p. 110 * DOI: http://dx.doi.org/10.1016/0378-1119(93)90258-5
	International search	[A]JP2003096099 (SHINO TEST CORP);
		[X]US2004141948 (O'KEEFE THERESA L [US]);
		[T]US2006057679 (O'KEEFE THERESA [US], et al);
		[X] - HORI O., "The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system", J. BIOL. CHEM., (19951027), vol. 270, no. 43, pages 25752 - 25761, XP002036217 DOI: http://dx.doi.org/10.1074/jbc.270.43.25752
	by applicant	US2003143194
		US2004141948
		- WITTEMANN ET AL., ARTHRITIS RHEUM., (1990), vol. 33, no. 13, pages 78 - 83
		- ROSENBERG ET AL., J RHEUMATOL., (2000), vol. 27, pages 2489 - 93
		- YAMADA ET AL., CLINICAL CHEMISTRY, AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, (2003), vol. 49, no. 9, pages 1535 - 11537
		- WINTER ET AL., ANNUAL REVIEW OF IMMUNOLOGY, (1993), vol. 12, pages 433 - 455
		- BALINT ET AL., GENE, (1993), vol. 137, no. 1, pages 109 - 118
		- WITTEMANN ET AL., ARTHRITIS RHEUM., (1990), vol. 33, pages 1378 - 83
		- Current Protocols in Molecular Biology, GREEN PUBLISHING ASSOCIATES, INC., (1989), vol. 1, pages 6.3.1 - 6.3.6

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p